RHYTHM PHARMACEUTICALS, INC. Cash and Restricted Cash
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Cash and Restricted Cash of $87.60 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-05-03
- 2021-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87.60M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $101.26M.
- 2020-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $68.07M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.49M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2021-03-31 | $87.60M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $101.26M 10-Q · filed 2021-05-03 |
| 2020-09-30 | $68.07M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $59.49M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $56.18M 10-Q · filed 2021-05-03 |
| 2019-12-31 | $62.70M 10-Q · filed 2021-05-03 |
| 2019-09-30 | $72.08M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $63.52M 10-Q · filed 2020-08-03 |
| 2019-03-31 | $42.42M 10-Q · filed 2020-05-04 |
| 2018-12-31 | $49.94M 10-K · filed 2021-03-01 |
| 2018-09-30 | $58.50M 10-Q · filed 2019-11-01 |
| 2018-06-30 | $210.73M 10-Q · filed 2019-07-29 |
| 2018-03-31 | $43.42M 10-Q · filed 2019-05-03 |
| 2017-12-31 | $34.46M 10-K · filed 2021-03-01 |
| 2017-09-30 | $28.14M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $8.95M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $12.11M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $6.76M 10-K · filed 2020-03-02 |
| 2015-12-31 | $35.09M 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |